Pterostilbene Mood Meta-analysis: What the Evidence Says
Pterostilbene Mood Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed
Quick Answer
Pterostilbene Mood Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 narrative review, 1 research article.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Pterostilbene Mood Meta-analysis: What the Evidence Says
Quick Answer
Pterostilbene Mood Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Stilbenes from Vine Extracts: Therapeutic Potential and Mechanisms | narrative review | 3 | 2025-08-26 | 10.3390/ijms26178269 |
| The therapeutic horizon of acute kidney injury in critical care: exploring pathology, promises, pitfalls, and progress | research article | 4 | 2025-12-01 | 10.1097/MCC.0000000000001331 |
What The Sources Report
- While viticulture brings substantial economic benefit to many countries, the growth in grape production has led to increased vineyard surface area and value, along with a rise in the accumulation of both organic and inorganic waste. [Brás Luís P. (2025); evidence level 3]
- Stilbenes are ideal candidates for high-value valorization in the field of cancer prevention and anticancer therapy since they are found in pruning waste. [Brás Luís P. (2025); evidence level 3]
- Khanna RCT 321 Catecholamine-resistant vasodilatory shock Increased liberation from RRT by day 7 Angiotensin II Placebo et al. [Vogelaar Yvo (2025); evidence level 4]
- Nagendran meta-analysis 1453 Septic shock A nonsignificant trend toward reduced RRT Vasopressin norepinephrine NCT05568160 RCT 1600 Cardiac surgery Incidence of stage 2-3 AKI Ongoing Terlipressin Standard of care et al. [Vogelaar Yvo (2025); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
For pterostilbene mood meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Brás Luís P. (2025). Stilbenes from Vine Extracts: Therapeutic Potential and Mechanisms. DOI: 10.3390/ijms26178269. PMCID: PMC12427932. PMID: 40943191. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12427932/
- Vogelaar Yvo (2025). The therapeutic horizon of acute kidney injury in critical care: exploring pathology, promises, pitfalls, and progress. DOI: 10.1097/MCC.0000000000001331. PMCID: PMC12594150. PMID: 41191836. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open a.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12594150/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed August 15, 2026 by Migaku Evidence Review
